(26 days)
The SYSTEM 1 endo Liquid Chemical Sterilant Processing System is intended for liquid chemical sterilization of cleaned, immersible, and reusable sensitive medical devices and their accessories in healthcare facilities.
The SYSTEM 1 endo Processor automatically dilutes the S40 Sterilant Concentrate to its use dilution (> 1820 mg/L peracetic acid), liquid chemically sterilizes the load during a controlled 6-minute exposure at 45.5 to 60°C and rinses the load with 0.2 micron filtered water.
The SYSTEM 1 endo Processor uses only S40 Sterilant Concentrate to liquid chemically sterilize medical devices.
The SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900 (S1 endo) is a liquid chemical sterilization system, utilizing peracetic acid to process totally immersible semi-critical heat-sensitive medical devices and their accessories. The system consists of the SYSTEM 1 endo Processor and S40 Sterilant concentrate, interchangeable Processing Trays/Containers, and Quick Connects.
The S1 endo Processor is an automated, self-contained device that uses S40 Sterilant Concentrate to create and maintain the conditions necessary for liquid chemical sterilization in 6 minutes. After LCS processing, the liquid chemically sterilized articles are rinsed with 0.2 micron filtered potable water and are ready for use or may be prepared for storage.
The S1 endo Processor uses only S40 Sterilant Concentrate. Upon loading the single-use cup, the active ingredient in S40, peracetic acid, is combined with inert ingredients (builders) to form a use dilution which inhibits corrosion of metals, polymers and other materials.
The interchangeable processing trays/containers are made to accommodate a variety of semi-critical instrument types and models. Each container is designed to maintain instruments in position while specific S1 endo Quick Connects, if required, facilitate delivery of the sterilant use-solution and rinse water to internal channels.
The STERIS Corporation's SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900, demonstrates substantial equivalence to its predicate device (K222615) based on non-clinical testing. The device is a liquid chemical sterilization system intended for processing immersible, reusable semi-critical medical devices and their accessories in healthcare facilities. The modifications being reviewed are limited to the use of alternative, drop-in replacement components for the control boards.
Here's a breakdown of the acceptance criteria and the study that proves the device meets them:
1. A table of acceptance criteria and the reported device performance:
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Use of new control boards: | |
| New control boards must fit. | Pass (demonstrated by testing) |
| New control boards must run all cycles. | Pass (demonstrated by testing) |
| New control boards must run without alarms. | Pass (demonstrated by testing) |
| Software confirmation test: | |
| Ensure proper software version. | Pass (demonstrated by testing) |
| Ensure proper operation of cycles. | Pass (demonstrated by testing) |
| Ensure proper operation of alarms. | Pass (demonstrated by testing) |
2. Sample size used for the test set and the data provenance:
The document mentions "non-clinical performance testing" and "the same methods used to verify the original design" but does not specify the exact sample size for the test set (e.g., number of sterilization cycles performed, number of control boards tested).
The data provenance is implicitly from STERIS Corporation's internal testing labs, as they designed and manufactured the device. The testing is retrospective in the sense that it's performed after the modifications were made to confirm functionality against established criteria. No external country of origin is mentioned for the testing data itself; it's generated by the manufacturer for regulatory submission in the U.S.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not provided in the document. The testing appears to be objective, verifying technical specifications and operational parameters, rather than requiring expert interpretation for ground truth establishment in the traditional sense of medical image analysis or clinical diagnosis. The "ground truth" here is the expected functional performance of the device and its components.
4. Adjudication method for the test set:
This information is not provided as the nature of the testing (functional verification of control boards and software) would likely involve automated system checks and predefined pass/fail criteria rather than expert adjudication of subjective results.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:
This is not applicable as the device is a liquid chemical sterilant processing system, not an AI-powered diagnostic or assistive tool for human readers. No MRMC study was performed.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
This is not applicable for the same reasons as #5. The device operates as an automated system; there isn't an "algorithm only" performance that would need to be separated from human interaction in the way an AI diagnostic tool might.
7. The type of ground truth used:
The ground truth used for these specific tests (related to new control boards and software) is functional criteria and predefined technical specifications. For example, a control board "fits" if it physically integrates correctly, "runs all cycles" if it successfully initiates and completes the sterilization sequence, and "runs without alarms" if no error states are triggered during operation. The software's "proper version" is a verifiable identifier, and its "proper operation of cycles and alarms" refers to its adherence to programmed logic and responses.
More broadly for the device as a sterilizer, the ultimate ground truth would be microbial efficacy (sterilization) and material compatibility, which are also stated to meet efficacy requirements based on in-vitro testing for its intended use (as described in Table 2).
8. The sample size for the training set:
This information is not applicable. The device is a physical sterilizer with a control system, not a machine learning or AI model that requires a training set. The "training" for such a system would be its design, engineering, and manufacturing processes, along with verification and validation testing.
9. How the ground truth for the training set was established:
This is not applicable as there is no "training set" in the context of an AI/ML model for this device. The ground truth for the device's overall function (sterilization efficacy) is established through standardized microbiological testing methods (e.g., AOAC Official Methods, simulated-use tests, clinical in-use tests as referenced in Table 2) against specific log reduction criteria for various microorganisms. For component performance (like the control boards), the ground truth is established by design specifications and functional requirements.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
March 28, 2023
STERIS Corporation Jennifer Nalepka Manager, Regulatory Affairs 5960 Heisley Road Mentor, Ohio 44060
Re: K230582
Trade/Device Name: SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900 Regulation Number: 21 CFR 880.6885 Regulation Name: Sterilant, Medical Devices, Liquid Chemical Sterilants/Disinfectants Regulatory Class: Class II Product Code: MED Dated: March 1, 2023 Received: March 2, 2023
Dear Jennifer Nalepka:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Clarence W. Murray III -S
Clarence W. Murray III, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K230582
Device Name
SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900
Indications for Use (Describe)
The SYSTEM 1 endo Liquid Chemical Sterilant Processing System is intended for liquid chemical sterilization of cleaned, immersible, and reusable sensitive medical devices and their accessories in healthcare facilities.
The SYSTEM 1 endo Processor automatically dilutes the S40 Sterilant Concentrate to its use dilution (> 1820 mg/L peracetic acid), liquid chemically sterilizes the load during a controlled 6-minute exposure at 45.5 to 60°C and rinses the load with 0.2 micron filtered water.
The SYSTEM 1 endo Processor uses only S40 Sterilant Concentrate to liquid chemically sterilize medical devices.
| Type of Use (Select one or both, as applicable) |
|---|
| Prescription Use (Part 21 CFR 801 Subpart D) |
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the STERIS logo. The word "STERIS" is in large, bold, black font at the top of the image. Below the word is a graphic of several horizontal blue lines that are curved to resemble waves.
510(k) Summary For SYSTEM 1 endo Liquid Chemical Sterilant Processing System Model P6900
STERIS Corporation 5960 Heisley Road Mentor, OH 44060 Phone: (440) 354-2600
Contact:
Jennifer Nalepka Manager, Regulatory Affairs Phone: (440) 392-7458 Email: jennifer nalepka@steris.com
March 1, 2023 Summary Date:
STERIS Corporation ■ 5960 Heisley Road ■ Mentor, OH 44060-1834 USA ■ 440-354-2600
{4}------------------------------------------------
1. Device Name
| Trade Name: | SYSTEM 1 endo Liquid Chemical Sterilant ProcessingSystem, Model P6900 |
|---|---|
| Device Class: | Class II |
| Common/Usual Name: | Liquid Chemical Sterilizer |
| Classification Name: | Sterilant, Medical Devices, Liquid ChemicalSterilants/Disinfectants |
| Classification Number: | 21 CFR 880.6885 |
| Product Code: | MED |
2. Predicate Device
SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900, K222615
3. Description of Device
The SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900 (S1 endo) is a liquid chemical sterilization system, utilizing peracetic acid to process totally immersible semi-critical heat-sensitive medical devices and their accessories. The system consists of the SYSTEM 1 endo Processor and S40 Sterilant concentrate, interchangeable Processing Trays/Containers, and Quick Connects.
The S1 endo Processor is an automated, self-contained device that uses S40 Sterilant Concentrate to create and maintain the conditions necessary for liquid chemical sterilization in 6 minutes. After LCS processing, the liquid chemically sterilized articles are rinsed with 0.2 micron filtered potable water and are ready for use or may be prepared for storage.
The S1 endo Processor uses only S40 Sterilant Concentrate. Upon loading the single-use cup, the active ingredient in S40, peracetic acid, is combined with inert ingredients (builders) to form a use dilution which inhibits corrosion of metals, polymers and other materials.
The interchangeable processing trays/containers are made to accommodate a variety of semi-critical instrument types and models. Each container is designed to maintain instruments in position while specific S1 endo Quick Connects, if required, facilitate delivery of the sterilant use-solution and rinse water to internal channels. Tables 1 and 2 compare the proposed and predicate devices.
4. Indications for Use
The SYSTEM 1 endo Liquid Chemical Sterilant Processing System is intended for liquid chemical sterilization of cleaned, immersible, and reusable semi-critical heat-sensitive medical devices and their accessories in healthcare facilities.
The SYSTEM 1 endo Processor automatically dilutes the S40 Sterilant Concentrate to its use dilution (> 1820 mg/L peracetic acid), liquid chemically sterilizes the load during a controlled 6-minute exposure at 45.5 to 60°C and rinses the load with 0.2 micron filtered water.
{5}------------------------------------------------
The SYSTEM 1 endo Processor uses only S40 Sterilant Concentrate to liquid chemically sterilize medical devices.
5. Technical Characteristic Comparison Table
The S1 endo is the same as the predicate device with the exception of the proposed modification. A comparison between the proposed and predicate devices can be found in Table 1 and Table 2 below.
| Feature | Proposed DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900 | Predicate DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900(K222615) | Comparison |
|---|---|---|---|
| IntendedUseIndicationsfor Use | The SYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem is intended for liquidchemical sterilization of cleaned,immersible, and reusable semi-critical heat-sensitive medicaldevices and their accessories inhealthcare facilities.The SYSTEM 1 endo Processorautomatically dilutes the S40Sterilant Concentrate to its usedilution (> 1820 mg/L peraceticacid), liquid chemically sterilizesthe load during a controlled 6-minute exposure at 45.5 to 60°C,and rinses the load with 0.2micron filtered water.The SYSTEM 1 endo Processoruses only S40 SterilantConcentrate to liquid chemicallysterilize medical devices. | The SYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem is intended for liquidchemical sterilization of cleaned,immersible, and reusable semi-critical heat-sensitive medicaldevices and their accessories inhealthcare facilities.The SYSTEM 1 endo Processorautomatically dilutes the S40Sterilant Concentrate to its usedilution (> 1820 mg/L peraceticacid), liquid chemically sterilizesthe load during a controlled 6-minute exposure at 45.5 to 60°C,and rinses the load with 0.2micron filtered water.The SYSTEM 1 endo Processoruses only S40 SterilantConcentrate to liquid chemicallysterilize medical devices. | Identical |
| OperatingPrinciples/Technology | A microprocessor controlled unit with interchangeable processing trays/containers. The processor lid opens to reveal the processing chamber in which the load is placed. Devices with internal lumens are interfaced with the processor using connectors, i.e. Quick Connects | A microprocessor controlled unit with interchangeable processing trays/containers. The processor lid opens to reveal the processing chamber in which the load is placed. Devices with internal lumens are interfaced with the processor using connectors, i.e. Quick Connects. | Identical |
| Feature | Proposed DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900 | Predicate DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900(K222615) | Comparison |
| S40 Sterilant is placed in a specialized compartment and when the processor fills with water, it creates the sterilant use dilution from the single use sterilant cup. The processor monitors and controls the use dilution temperature and contact time. The processor automatically rinses the load with 0.2 micron filtered water to remove sterilant residuals. | S40 Sterilant is placed in a specialized compartment and when the processor fills with water, it creates the sterilant use dilution from the single use sterilant cup. The processor monitors and controls the use dilution temperature and contact time. The processor automatically rinses the load with 0.2 micron filtered water to remove sterilant residuals. | ||
| ProcessParameters | Standardized cycle parameters cannot be altered by operator. The critical process parameters are: Use dilution contact time Use dilution temperature Peracetic acid concentration Integrity of the internal water filter (tested by the system) | Standardized cycle parameters cannot be altered by operator. The critical process parameters are: Use dilution contact time Use dilution temperature Peracetic acid concentration Integrity of the internal water filter (tested by the system) | Identical |
| ProcessMonitors: | Cycle Printout documents successful cycle completion or identifies fault if cycle aborts Alarms if thermocouples indicate temperature out of specification Alarms if pressure switch indicates that high pressure pump is not operating Alarms if conductivity probe indicated conductivity specification not met Alarms if pressure transducer indicates circulation pressure is out of specification in Diagnostic cycle Alarms if pressure transducer indicates internal water filter failed integrity test | Cycle Printout documents successful cycle completion or identifies fault if cycle aborts Alarms if thermocouples indicate temperature out of specification Alarms if pressure switch indicates that high pressure pump is not operating Alarms if conductivity probe indicated conductivity specification not met Alarms if pressure transducer indicates circulation pressure is out of specification in Diagnostic cycle Alarms if pressure transducer indicates internal water filter failed integrity test | Identical |
| DesignFeatures | Microprocessor controlled unalterable and standardized | Microprocessor controlled unalterable and standardized | Identical |
| Feature | Proposed DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900 | Predicate DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900(K222615) | Comparison |
| liquid chemical sterilizationand Diagnostic cycles Intended for use only withS40 Sterilant Concentrate Automated dilution anddelivery of S40 Sterilant Processor provides 0.2 micronfiltered water for liquidchemical sterilization andrinsing Make-up air for processorduring drain sequences isfiltered through a 0.2 micronmembrane air filter Includes a barcode scanner;employs touchscreen displayinterface; has USB drive forelectronic cycle download;facilitates use of a web-baseddata management system. Separate, optional printer | liquid chemical sterilizationand Diagnostic cycles Intended for use only withS40 Sterilant Concentrate Automated dilution anddelivery of S40 Sterilant Processor provides 0.2 micronfiltered water for liquidchemical sterilization andrinsing Make-up air for processorduring drain sequences isfiltered through a 0.2 micronmembrane air filter Includes a barcode scanner;employs touchscreen displayinterface; has USB drive forelectronic cycle download;facilitates use of a web-baseddata management system. Separate, optional printer | ||
| Cycle Parameters | |||
| Incomingwater temp. | $\geq 43°C$ | $\geq 43°C$ | Identical |
| Temperatureto startsterilantexposure | $\geq 46°C$ | $\geq 46°C$ | Identical |
| Temperaturealarm pointduring LCSexposure | $< 45.5$ or $> 60°C$ | $< 45.5$ or $> 60°C$ | Identical |
| Temperaturerange oftypical LCScycle | 46 - 55°C | 46 - 55°C | Identical |
| ExposureTime - S40use dilution | 6 minutes | 6 minutes | Identical |
| Rinse waterpreparation | Hot potable tap water is pre-filtered is filtered through 0.2 micronbacterial retentive membranefilter | Hot potable tap water is pre-filtered is filtered through 0.2 micronbacterial retentive membranefilter | Identical |
| Feature | Proposed DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900 | Predicate DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900(K222615) | Comparison |
| Number ofrinses | 2 | 2 | Identical |
| Air Purge | Aids in removing excess waterfrom instrument lumens afterrinsing | Aids in removing excess waterfrom instrument lumens afterrinsing | Identical |
| InternalWater FilterIntegrity Test | Conducted during the Diagnosticcycle | Conducted during the Diagnosticcycle | Identical |
| ApproximateCycle Time | 18 - 20 minutes | 18 - 20 minutes | Identical |
| DiagnosticCycle | Performs 14 tests on processor'ssystems confirming properfunction. Recommended toperform each day of use. After afailed Diagnostic cycle, a liquidchemical sterilization cyclecannot be performed until theproblem is rectified and asuccessful Diagnostic cycle hasbeen completed. | Performs 14 tests on processor'ssystems confirming properfunction. Recommended toperform each day of use. After afailed Diagnostic cycle, a liquidchemical sterilization cyclecannot be performed until theproblem is rectified and asuccessful Diagnostic cycle hasbeen completed. | Identical |
| Accessories | |||
| Sterilant | Uses S40 Sterilant Concentrate | Uses S40 Sterilant Concentrate | Identical |
| ProcessingTrays andContainers | Uses interchangeable processingtrays/containers• Universal Flex Processing Tray• General Processing Container& Tray• Directed Flow ProcessingContainer & Tray• Flexible Endoscope ProcessingContainer & Tray• Ultrasound Processing Tray | Uses interchangeable processingtrays/containers• Universal Flex Processing Tray• General Processing Container& Tray• Directed Flow ProcessingContainer & Tray• Flexible Endoscope ProcessingContainer & Tray• Ultrasound Processing Tray | Identical |
| QuickConnects | Uses Quick Connects to attachinstrument lumens to theTray/Container ports | Uses Quick Connects to attachinstrument lumens to theTray/Container ports | Identical |
| ChemicalIndicator | VERIFY Chemical Indicator forS40 Sterilant is available for usein SYSTEM 1 endo LCSPS | VERIFY Chemical Indicator forS40 Sterilant is available for usein SYSTEM 1 endo LCSPS | Identical |
| Spore TestStrip | VERIFY Spore Test Strip for S40Sterilant for use in SYSTEM 1endo LCSPS | VERIFY Spore Test Strip for S40Sterilant for use in SYSTEM 1endo LCSPS | Identical |
| Feature | Proposed DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900 | Predicate DeviceSYSTEM 1 endo LiquidChemical Sterilant ProcessingSystem, Model P6900(K222615) | Comparison |
| OperatorMaintenance | Periodic replacement of waterfilters and air filter.Periodic replacement of printertape, if using the external printeroption. | Periodic replacement of waterfilters and air filter.Periodic replacement of printertape, if using the external printeroption. | Identical |
Table 1. Processor Comparison Table.
{6}------------------------------------------------
{7}------------------------------------------------
{8}------------------------------------------------
{9}------------------------------------------------
| Table 2. S40 Sterilant Concentrate Comparison Table | ||
|---|---|---|
| Feature | Proposed DeviceS40 Sterilant Concentrate | Predicate DeviceS40 Sterilant Concentrate(K222615) | Comparison |
|---|---|---|---|
| Indications forUse | The SYSTEM 1E Processoruses only S40 SterilantConcentrate to liquid chemicallysterilize medical devices. | The SYSTEM 1E Processoruses only S40 SterilantConcentrate to liquid chemicallysterilize medical devices. | Identical |
| Germicidalclaim | Liquid Chemical Sterilant | Liquid Chemical Sterilant | Identical |
| GermicideExposureTime (min) forintended use | 6 | 6 | Identical |
| UseTemperature | 45.5-60°C – allowable46-55°C - typicalPotency and simulated useevaluations conducted at <43°C | 45.5-60°C – allowable46-55°C - typicalPotency and simulated useevaluations conducted at <43°C | Identical |
| Reuse | Single use | Single use | Identical |
| HumanFactors | Dispensed ready to use.Container is opened and dilutedby the processor, thus limitinguser exposure to the activeingredient | Dispensed ready to useContainer is opened and dilutedby the processor, thus limitinguser exposure to the activeingredient | Identical |
| ActiveIngredient | 35% peroxyacetic (peracetic)acid automatically diluted foruse in the SYSTEM 1EProcessor. | 35% peroxyacetic (peracetic)acid automatically diluted foruse in the SYSTEM 1EProcessor. | Identical |
| Mode ofAction | It is believed that peracetic acidexerts its germicidal effect byseveral mechanisms:-oxidizing sulfhydryl and sulfurbonds in proteins and enzymes,particularly in the cell walls 1-hydroxyl radicals producedfrom PAA are bactericidal 2 | It is believed that peracetic acidexerts its germicidal effect byseveral mechanisms:-oxidizing sulfhydryl and sulfurbonds in proteins and enzymes,particularly in the cell walls1-hydroxyl radicals produced fromPAA are bactericidal2 | Identical |
| Feature | Proposed DeviceS40 Sterilant Concentrate | Predicate DeviceS40 Sterilant Concentrate(K222615) | Comparison |
| Rinses | -PAA damages the viral capsidand viral nucleic acid3,4. | -PAA damages the viral capsidand viral nucleic acid3,4 | Identical |
| Automatic, UV-irradiated, dual0.1 micron filtered, potable hotwater. | Automatic, UV-irradiated, dual0.1 micron filtered, potable hotwater. | ||
| Microbial Efficacy | |||
| SporicidalActivity ofDisinfectantsAOACOfficialMethod 966.04 | Meets efficacy requirements5.Bacillus subtilisClostridium sporogenesTesting conducted in vitro | Meets efficacy requirements5.Bacillus subtilisClostridium sporogenesTesting conducted in vitro | Identical |
| ConfirmatorySporicidalActivity ofDisinfectantsAOACOfficialMethod 966.04 | Meets efficacy requirements6.Bacillus subtilisClostridium sporogenesTesting conducted in vitro | Meets efficacy requirements6.Bacillus subtilisClostridium sporogenesTesting conducted in vitro | Identical |
| FungicidalActivity ofDisinfectantsAOACOfficialMethod 955.17 | Solution is fungicidal.Trichophyton mentagrophytesTesting conducted in vitro | Solution is fungicidal.Trichophyton mentagrophytesTesting conducted in vitro | Identical |
| Use DilutionMethodAOAC,OfficialMethods955.14, 955.15,964.02 | Solution is bactericidal.Salmonella choleraesuisStaphylococcus aureusPseudomonas aeruginosaTesting conducted in vitro | Solution is bactericidal.Salmonella choleraesuisStaphylococcus aureusPseudomonas aeruginosa | Identical |
| EPA ViricidalTesting(DIS/TSS-7,Nov. 1981) | Solution is viricidal.Herpes simplex Type 1Adenovirus Type 5Poliovirus Type 1Testing conducted in vitro | Solution is viricidal.Herpes simplex Type 1Adenovirus Type 5Poliovirus Type 1Testing conducted in vitro | Identical |
| TuberculocidalActivityAscenziQuantitativeSuspensionTest | Solution is tuberculocidalMycobacterium terraeTesting conducted in vitro | Solution is tuberculocidalMycobacterium terraeTesting conducted in vitro | Identical |
| Feature | Proposed DeviceS40 Sterilant Concentrate | Predicate DeviceS40 Sterilant Concentrate(K222615) | Comparison |
| Simulated-UseTest | Meets efficacy requirement.$\geq$ 6 log reduction Geobacillusstearothermophilus spores in amanual application | Meets efficacy requirement.$\geq$ 6 log reduction Geobacillusstearothermophilus spores in amanual application | Identical |
| Clinical In-Use | No surviving microorganismson representative medicaldevices tested | No surviving microorganisms onrepresentative medical devicestested | Identical |
| Biocompatibility | |||
| CytotoxicityDevice Extracts | Two rinses with UV treated,dual 0.1-micron membranefiltered water effectively reducesterilant residues to safe levels. | Two rinses with UV treated, dual0.1-micron membrane filteredwater effectively reduce sterilantresidues to safe levels. | Identical |
| ResidueReduction | Automatic within the SYSTEM1E Processor:Two rinses with UV treated,dual 0.1-micron membranefiltered water effectively reducesterilant residues to safe levels. | Automatic within the SYSTEM1E Processor:Two rinses with UV treated, dual0.1-micron membrane filteredwater effectively reduce sterilantresidues to safe levels. | Identical |
| DeviceMaterialCompatibility | Compatible with medicaldevices as established bytesting finished flexibleendoscopes through 300 cyclesand rigid devices through 150cycles.No functional changes haveoccurred to flexible devices.Some materials show cosmeticchanges such as fading of blackanodized aluminum withoutharm to the base material. | Compatible with medicaldevices as established by testingfinished flexible endoscopesthrough 300 cycles and rigiddevices through 150 cycles.No functional changes haveoccurred to flexible devices.Some materials show cosmeticchanges such as fading of blackanodized aluminum withoutharm to the base material. | Identical |
1 Block, S. ed., Disinfection, Sterilization, and Preservation. 5th edition, 2001.
2 Clapp et al., Free Rad. Res., (1994) 21:147-167.
² Clapp et al., Free Rad. Res., (1994) 21:147-167.
{10}------------------------------------------------
³ Maillard et. al., J. Med. Microbiol (1995) 42:415-420.
4 Maillard et. al., J. Appl Bacteriol (1996) 80:540-554.
5 McDonnell et al., J. ADAC International (2000) 83:269-276.
{11}------------------------------------------------
The proposed device has the same intended use as the predicate with the same technological characteristics. The modifications, subject of this submission, are to use control boards that have been slightly modified by using alternative, drop-in replacement components in the manufacture of the devices.
6. Summary of Non-Clinical Testing
Non-clinical performance testing was performed according to the test methodology listed below and is the same methods used to verify the original design. The testing demonstrated that the subject device met the acceptance criteria described in the standard/methodology.
{12}------------------------------------------------
| Test | Criterion | Conclusion |
|---|---|---|
| Use of new control boards | New control boards must fit and run all cycles without alarms | Pass |
| Software confirmation test | Ensure proper version, proper operation of cycles and alarms | Pass |
Table 3. Summary of Non-Clinical Testing
7. Conclusion
The conclusions drawn from the non-clinical performance data, the SYSTEM 1 endo Liquid Chemical Sterilant Processing System is as safe, as effective, and performs as well or better than the legally marketed predicate device K222615, Class II (21 CFR 880.6885), product code MED.
§ 880.6885 Liquid chemical sterilants/high level disinfectants.
(a)
Identification. A liquid chemical sterilant/high level disinfectant is a germicide that is intended for use as the terminal step in processing critical and semicritical medical devices prior to patient use. Critical devices make contact with normally sterile tissue or body spaces during use. Semicritical devices make contact during use with mucous membranes or nonintact skin.(b)
Classification. Class II (special controls). Guidance on the Content and Format of Premarket Notification (510(k)) Submissions for Liquid Chemical Sterilants/High Level Disinfectants, and user information and training.